Skip to main content
Dapagliflozin’s HFpEF benefit tied to lower filling pressure
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Dapagliflozin’s HFpEF benefit tied to lower filling pressure
User login
Username
Password
Reset your password
Concept
Lead
score
Heart Failure (HF)
1
1
Cardiovascular Imaging
0
0.69
Heart
0
0.69
Cardiomyopathy
0
0.6
Exercise
0
0.43
Type 2 Diabetes Mellitus
0
0.36
SGLT2 Inhibitor
0
0.35
Obesity
0
0.33
Capillary
0
0.26
Ejection Fraction
0
0.99
Hemodynamics
0
0.17
Clinical Research
0
0.09
Dyspnea
0
0.09
Healthcare and Medical Technology
0
0.09
Metabolism
0
0.09
New York
0
0.09
Pericardial Disease
0
0.09
Plasma
0
0.09
Type 1 Diabetes Mellitus
0
0.09
Weight Loss
0
0.09
Weight Management
0
0.09
Specialty
Lead
score
Cardiology
1
1
Diabetes & Endocrinology
0
0.9
Family Medicine/Primary Care
0
0.8
Internal Medicine
0
0.7
Edit Tags